Medical Journals

Marked Insulin Resistance in Obese Spontaneously Hypertensive Rat Adipocytes is Ameliorated by in Vivo but Not in Vitro Treatment with Moxonidine.

Authors:
  • Sun Zheng
  • Ernsberger Paul

From: Department of Nutrition, Case Western Reserve University School of Medicine, Cleveland, OH 44106-4906, USA.

The Journal of pharmacology and experimental therapeutics

  • Publish Date: Feb 2007
  • ISSN: 0022-3565
  • Volume: 320
  • Issue: 2
  • Pages: 845-52
  • Medium: Print
  • Language: English
  • Citation (JAMA): Sun Zheng, Ernsberger Paul, et al. Marked Insulin Resistance in Obese Spontaneously Hypertensive Rat Adipocytes is Ameliorated by in Vivo but Not in Vitro Treatment with Moxonidine.. J. Pharmacol. Exp. Ther. Feb 2007;320:845-52

Abstract

The obese spontaneously hypertensive rat (SHROB) is a model of marked insulin resistance with normoglycemia. We sought to determine whether insulin resistance extends to adipocytes and the impact of an insulin-sensitizing imidazoline, moxonidine (4 mg/kg/days for 21 days). Gonadal adipocytes were isolated from SHROB and lean spontaneously hypertensive rat (SHR) littermates. In lean SHR adipocytes, Akt activation by 100 nM insulin peaked at 3 min at 25-fold, whereas SHROB adipocytes showed only 4-fold activation. In dose-response experiments, the maximal response (E(max)) was markedly reduced 18.8 +/- 2.3 versus 3.7 +/- 0.8. Insulin sensitivity was also attenuated, with higher concentrations required for responses (EC(50) = 3.5 +/- 0.5 versus 29 +/- 3.8 nM). Glucose uptake as determined with [(3)H]2-deoxyglucose was also less responsive to insulin in SHROB relative to lean SHR. Moxonidine had little or no effect when applied acutely in vitro, but adipocytes isolated from SHROB treated with moxonidine in vivo showed significantly improved responses to insulin, both in terms of Akt activation and facilitation of glucose uptake. Chronic but not acute moxonidine treatment partially restores insulin sensitivity in SHROB adipocytes, suggesting an indirect action of this agent.

Mesh Headings (Keywords): Adipocytes, Animals, Dose-Response Relationship, Drug, Female, Glucose, Hypertension, Imidazoles, Insulin Resistance, Male, Obesity, Phosphorylation, Proto-Oncogene Proteins c-akt, Rats, Rats, Inbred SHR


Check for Full Text / PubMed Unique Identifier (PMID): 17095615


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.